Suppr超能文献

耳蜗植入术后前庭神经鞘瘤切除的结果:系统评价。

Cochlear Implant Outcomes Following Vestibular Schwannoma Resection: Systematic Review.

机构信息

Department of Otolaryngology-Head and Neck Surgery.

Program in Audiology and Communication Sciences, Department of Otolaryngology-Head and Neck Surgery.

出版信息

Otol Neurotol. 2020 Oct;41(9):1190-1197. doi: 10.1097/MAO.0000000000002784.

Abstract

OBJECTIVE

Hearing loss remains a significant morbidity for patients with vestibular schwannomas (VS). A growing number of reports suggest audibility with cochlear implantation following VS resection; however, there is little consensus on preferred timing and cochlear implant (CI) performance.

DATA SOURCES

A systematic literature search of the Ovid Medline, Embase, Scopus, and clinicaltrails.gov databases was performed on 9/7/2018. PRISMA reporting guidelines were followed.

STUDY SELECTION

Included studies reported CI outcomes in an ear that underwent a VS resection. Untreated VSs, radiated VSs, and CIs in the contralateral ear were excluded.

DATA EXTRACTION

Primary outcomes were daily CI use and attainment of open-set speech. Baseline tumor and patient characteristics were recorded. Subjects were divided into two groups: simultaneous CI placement with VS resection (Group 1) versus delayed CI placement after VS resection (Group 2).

DATA SYNTHESIS

Twenty-nine articles with 93 patients met inclusion criteria. Most studies were poor quality due to their small, retrospective design. Group 1 had 46 patients, of whom 80.4% used their CI on a daily basis and 50.0% achieved open-set speech. Group 2 had 47 patients, of whom 87.2% used their CI on a daily basis and 59.6% achieved open-set speech. Group 2 had more NF2 patients and larger tumors. CI timing did not significantly impact outcomes.

CONCLUSIONS

Audibility with CI after VS resection is feasible. Timing of CI placement (simultaneous versus delayed) did not significantly affect performance. Overall, 83.9% used their CI on a daily basis and 54.8% achieved open-set speech.

摘要

目的

听神经瘤(VS)患者仍存在听力损失这一重大发病率。越来越多的报告表明,在 VS 切除后进行耳蜗植入可以提高可听度;然而,对于最佳时机和耳蜗植入(CI)性能,目前仍缺乏共识。

资料来源

2018 年 9 月 7 日,对 Ovid Medline、Embase、Scopus 和 clinicaltrails.gov 数据库进行了系统的文献检索。遵循 PRISMA 报告指南。

研究选择

纳入的研究报告了接受 VS 切除术的耳朵的 CI 结果。未治疗的 VS、放射性 VS 和对侧耳朵中的 CI 被排除在外。

数据提取

主要结果是日常 CI 使用和开放式语音的获得。记录了基线肿瘤和患者特征。受试者分为两组:VS 切除同时进行 CI 植入(组 1)与 VS 切除后延迟 CI 植入(组 2)。

数据综合

符合纳入标准的 29 篇文章,共 93 例患者。由于其小样本、回顾性设计,大多数研究质量较差。组 1 有 46 例患者,其中 80.4%的患者每天使用 CI,50.0%的患者实现了开放式语音。组 2 有 47 例患者,其中 87.2%的患者每天使用 CI,59.6%的患者实现了开放式语音。组 2 有更多的 NF2 患者和更大的肿瘤。CI 时机并未显著影响结果。

结论

VS 切除后使用 CI 实现可听度是可行的。CI 放置的时机(同时与延迟)并没有显著影响性能。总体而言,83.9%的患者每天使用 CI,54.8%的患者实现了开放式语音。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验